As previously described, the Oncomine database pinpointed a significant downregulation of LZTS1 mRNA expression in breast cancer samples (p<0.001), which was further confirmed by immunohistochemistry in a series of 270 breast cancers and 16 normal breast specimens. The gene discussed is LZTS1; the disease is breast cancer.